Selective modulation of estrogen receptor action.
作者信息
Sadovsky Y, Adler S
出版信息
J Clin Endocrinol Metab. 1998 Jan;83(1):3-5. doi: 10.1210/jcem.83.1.4588.
PMID:9435407
Abstract
摘要
相似文献
1
Selective modulation of estrogen receptor action.雌激素受体作用的选择性调节。
J Clin Endocrinol Metab. 1998 Jan;83(1):3-5. doi: 10.1210/jcem.83.1.4588.
2
Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles.
J Clin Endocrinol Metab. 1998 Jan;83(1):6-13. doi: 10.1210/jcem.83.1.4448.
3
Tamoxifen, raloxifene, and the prevention of breast cancer.他莫昔芬、雷洛昔芬与乳腺癌预防
Endocr Rev. 1999 Jun;20(3):253-78. doi: 10.1210/edrv.20.3.0368.
4
Raloxifene: magic bullet for heart and bone?雷洛昔芬：治疗心脏和骨骼疾病的神奇药物？
Nat Med. 1998 Feb;4(2):152-3. doi: 10.1038/nm0298-152.
5
Raloxifene: a selective estrogen receptor modulator.雷洛昔芬：一种选择性雌激素受体调节剂。
Am Fam Physician. 1999 Sep 15;60(4):1131-9.
6
Next generation of SERMs being seen in clinic.
J Natl Cancer Inst. 1997 Jul 2;89(13):913.
7
Selective estrogen receptor modulators and postmenopausal women's health.选择性雌激素受体调节剂与绝经后女性健康
J Womens Health. 1997 Oct;6(5):523-31. doi: 10.1089/jwh.1997.6.523.
8
Tissue-specific estrogens--the promise for the future.组织特异性雌激素——未来的希望。
N Engl J Med. 1997 Dec 4;337(23):1686-7. doi: 10.1056/NEJM199712043372309.
9
Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators.选择性雌激素受体调节剂对雌激素刺激的子宫平滑肌瘤生长的抑制作用。
Mol Carcinog. 1996 Nov;17(3):151-9. doi: 10.1002/(SICI)1098-2744(199611)17:3<151::AID-MC7>3.0.CO;2-I.
10
The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor.雷洛昔芬抗雌激素作用机制的关键在于雌激素受体中的351位氨基酸（天冬氨酸）。
Cancer Res. 1998 May 1;58(9):1872-5.
Zotero 插件